West Plans to Form Pharmaceutical Component Manufacturing Plant
West Pharmaceutical Services announced that they will form a new facility in Ireland for the production of insulin injector cartridge packaging components.
West Pharmaceutical Services announced on Oct. 2, 2014 that they plan to expand their manufacturing operations in Waterford, Ireland. West, which is internationally headquartered in Exton, Pennsylvania, produces standard-setting systems and device components for parenterally administered medicines. The new facility will produce packaging components for a variety of items, including insulin injector cartridges.
“With diabetes emerging as one of the fastest growing diseases globally, our pharmaceutical customers are expanding their production lines for injectable insulin. To meet this growing demand, we are announcing an expansion today that will help us address this need and continue to serve this critical patient population,” said Donald E. Morel, Jr., West’s chairman and CEO.
The construction, which will take place on a 44-acre site, is expected to begin in early 2015.
Source: West
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
